-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Oramed Pharmaceuticals Inc. quarterly Selling and Marketing Expense history and growth rate from Q3 2021 to Q3 2023.
- Oramed Pharmaceuticals Inc. Selling and Marketing Expense for the quarter ending September 30, 2023 was -$663K, a 243% decline year-over-year.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)